Tag Archives: Sclerosis

FDA Approves Ofev (nintedanib) for Interstitial Lung Disease Associated with Systemic Sclerosis or Scleroderma (SSc-ILD)

Print this page September 06, 2019 — The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition. “Patients suffering from… Read More »

Significance and Prevalence of Headache in Multiple Sclerosis – Clinical Pain Advisor

Migraine is at least 3 times more common in patients with multiple sclerosis (MS) than in the normal population, the significance of which is not well understood. Recent studies have indicated a preponderance of headache complaints in patients with MS that could be due to multiple etiologies. The majority of headaches reported in studies were… Read More »